Citation: Heping Hu, Lijia Yu, Zhao Ding, Jinsong Ding, Yiguo Hu, Zongning Yin. Chemo–immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes[J]. Chinese Chemical Letters, ;2023, 34(10): 108592. doi: 10.1016/j.cclet.2023.108592 shu

Chemo–immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes

Heping Hu ^a ,
Lijia Yu ^b ,
Zhao Ding ^c ,
Jinsong Ding ^d ,
Yiguo Hu ^e ,
Zongning Yin ^{a, *,}

a.
Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
b.
Sichuan Huiyu Seacross Medical Technology Co., Ltd., Chengdu 610031, China
c.
Sichuan Huiyu Pharmaceutical Co., Ltd., Neijiang 641000, China
d.
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
e.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610044, China

yzn@scu.edu.cn

Received Date: 5 February 2023
Revised Date: 13 May 2023
Accepted Date: 18 May 2023
Available Online: 19 May 2023

Figures(4)

Triple-negative breast cancer (TNBC) lacks specific regimens for targeted therapy. Repeat chemotherapy promotes the evolution of TNBC into highly chemo-resistant tumors that metastasize to multiple organs simultaneously. Herein, polyacrylic acid-coated ultrasmall superparamagnetic iron-oxide nanoparticles (PAA@IONs) and dual-targeting doxorubicin liposomes achieved chemo–immunotherapy through intermittent administration. They inhibited tumor-drug resistance and multiorgan-specific metastasis significantly by targeting tumors and the microenvironment. We deciphered an immunosuppressive pre-metastatic niche and discovered that PAA@IONs could target tumors, tumor-draining lymph nodes (TDLNs), the liver, bone, and lungs. They promoted the polarization of macrophages into M1 macrophages in these organs and tissues. This action remodeled the immunosuppressive microenvironment and induced a sustained immune response, thereby reducing organ-specific metastasis. Overcoming the disadvantages of doxorubicin-induced cardiotoxicity as well as low tumor specificity, dual peptide-modified liposomes could target CD206 and CD13 simultaneously, and reverse chemo-resistance. These properties resulted in a significant decrease in the numbers of myeloid-derived suppressor cells (MDSCs) and cancer stem cells (CSCs) in the liver, lungs, and bone, thereby reducing protein expression of Ki-67 in TDLNs, and dramatically increasing the number of cluster of differentiation (CD)8⁺T cells and CD8⁺ T cell/T-regulatory-cell ratio in tumors and TDLNs (P < 0.0001). Compared with the control (P < 0.05 and P < 0.01, respectively) or free drug (P < 0.0001 and P < 0.01, respectively), multi-organ metastases were suppressed significantly, tumor-growth rate reduced, and survival prolonged. Our drug-delivery system overcame TNBC chemo-resistance and inhibited multiorgan-specific metastases. It circumvents the lack of effective therapeutic targets, the problem of patient selection due to a low mutation rate, and can simultaneously offer the possibility of avoiding surgery and considerable postoperative complications.
- Multidrug resistance,
- Multiorgan-specific metastases,
- Immunogenic cell death,
- Intermittent dosing,
- Immunosuppressive tumor microenvironment,
- Tumor-associated macrophages
1. [1]
  L. Vecchi, S.T.S. Mota, M.A.P. Zoia, et al., Cells 11 (2022) 1705. doi: 10.3390/cells11101705
2. [2]
  X. Qiu, Y. Qu, B. Guo, et al., J. Control. Release. 341 (2022) 498–510. doi: 10.1016/j.jconrel.2021.12.002
3. [3]
  L. Biganzoli, N.M.L. Battisti, H. Wildiers, et al., Lancet Oncol. 22 (2021) e327–e340. doi: 10.1016/S1470-2045(20)30741-5
4. [4]
  D. Zhang, F. Feng, R. Liu, W. Zhu, L. Yao, Chin. Chem. Lett. 30 (2019) 7–14. doi: 10.1016/j.cclet.2018.06.011
5. [5]
  I. Fatima, I. El-Ayachi, H.C. Playa, et al., Cancers 11 (2019) 2039. doi: 10.3390/cancers11122039
6. [6]
  H. du Bois, T.A. Heim, A.W. Lund, Sci. Immunol. 6 (2021) eabg3551. doi: 10.1126/sciimmunol.abg3551
7. [7]
  Y.Y. Chen, J.Y. Ge, D. Ma, K.D. Yu, Front. Oncol. 10 (2020) 570981. doi: 10.3389/fonc.2020.570981
8. [8]
  D.I. Tsilimigras, P. Brodt, P.A. Clavien, et al., Nat. Rev. Dis. Primers 7 (2021) 27. doi: 10.1038/s41572-021-00261-6
9. [9]
  A.G. Waks, E.P. Winer, JAMA. 321 (2019) 288–300. doi: 10.1001/jama.2018.19323
10. [10]
  E. Avitabile, D. Bedognetti, G. Ciofani, A. Bianco, L.G. Delogu, Nanoscale 10 (2018) 11719–11731. doi: 10.1039/C8NR02796J
11. [11]
  V. Tripathi, J.H. Shin, C.H. Stuelten, Y.E. Zhang, Oncogene, 38 (2019) 3185–3200. doi: 10.1038/s41388-018-0655-8
12. [12]
  F. Emami, S. Pathak, T.T. Nguyen, et al., J. Control. Release. 329 (2021) 645–664. doi: 10.1016/j.jconrel.2020.10.001
13. [13]
  K. Irshad, C. Srivastava, N. Malik, et al., Front. Immunol. 13 (2022) 813888. doi: 10.3389/fimmu.2022.813888
14. [14]
  Y. Wang, J. Yu, Z. Luo, et al., Adv. Mater. 33 (2021) e2103497. doi: 10.1002/adma.202103497
15. [15]
  Y. Jiang, Y. Li, B. Zhu, Cell Death Dis. 6 (2015) e1792. doi: 10.1038/cddis.2015.162
16. [16]
  S. Zhu, N. Yang, J. Wu, Pharmacol. Res. 159 (2020) 104980. doi: 10.1016/j.phrs.2020.104980
17. [17]
  S. Zanganeh, G. Hutter, R. Spitler, et al., Nat. Nanotechnol. 11 (2016) 986–994. doi: 10.1038/nnano.2016.168
18. [18]
  R. Zhang, F. Qi, F. Zhao, et al., Cell Death Dis. 10 (2019) 273. doi: 10.1109/iecon.2019.8927061
19. [19]
  Z. Chen, J. Wu, L. Wang, H. Zhao, J. He, Med. Oncol. 39 (2022) 83. doi: 10.1007/s12032-022-01670-7
20. [20]
  L. Fu, X. Ma, Y. Liu, Z. Xu, Z. Sun, Chin. Chem. Lett. 33 (2022) 1718–1728. doi: 10.1016/j.cclet.2021.10.074
21. [21]
  J. Wang, D. Li, H. Cang, B. Guo, Cancer Med. 8 (2019) 4709–4721. doi: 10.1002/cam4.2327
22. [22]
  J. Chen, X. Yu, X. Liu, et al., Nanoscale 14 (2022) 12984–12998. doi: 10.1039/d2nr04418h
23. [23]
  L. Liu, F. Zeng, Y. Li, et al., Nanoscale 14 (2022) 4073–4081. doi: 10.1039/d1nr07449k
24. [24]
  S. Niu, G.R. Williams, J. Wu, et al., Chem. Eng. J. 369 (2019) 134–149. doi: 10.1016/j.cej.2019.02.201
25. [25]
  M. Louca, V. Gkretsi, Cancers 14 (2022) 4528. doi: 10.3390/cancers14184528
26. [26]
  M.F. Fransen, M. Schoonderwoerd, P. Knopf, et al., JCI Insight 3 (2018) e124507. doi: 10.1172/jci.insight.124507
27. [27]
  X. Zhu, L. Chen, B. Huang, et al., Sci. Rep. 10 (2020) 225. doi: 10.1038/s41598-019-57094-3
28. [28]
  Y. Chu, T. Sun, C. Jiang, Chin. Chem. Lett. 33 (2022) 4157–4168. doi: 10.1016/j.cclet.2022.02.051
29. [29]
  L. Yang, P. Shi, G. Zhao, J. Xu, et al., Signal Transduct. Target. Ther. 5 (2020) 8. doi: 10.1089/acm.2019.0105
30. [30]
  K. Hu, H. Zhou, Y. Liu, et al., Nanoscale 7 (2015) 8607–8618. doi: 10.1039/C5NR01084E
1. [1]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
2. [2]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
3. [3]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
4. [4]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
5. [5]
  Xiaohong Wen , Mei Yang , Lie Li , Mingmin Huang , Wei Cui , Suping Li , Haiyan Chen , Chen Li , Qiuping Guo . Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters, 2024, 35(8): 109291-. doi: 10.1016/j.cclet.2023.109291
6. [6]
  Ying Gao , Rong Zhou , Qiwen Wang , Shaolong Qi , Yuanyuan Lv , Shuang Liu , Jie Shen , Guocan Yu . Natural killer cell membrane doped supramolecular nanoplatform with immuno-modulatory functions for immuno-enhanced tumor phototherapy. Chinese Chemical Letters, 2024, 35(10): 109521-. doi: 10.1016/j.cclet.2024.109521
7. [7]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
8. [8]
  Lixian Fu , Yiyun Tan , Yue Ding , Weixia Qing , Yong Wang . Water–soluble and polarity–sensitive near–infrared fluorescent probe for long–time specific cancer cell membranes imaging and C. Elegans label. Chinese Chemical Letters, 2024, 35(4): 108886-. doi: 10.1016/j.cclet.2023.108886
9. [9]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
10. [10]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755
11. [11]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
12. [12]
  Zhe Li , Ping-Zhao Liang , Li Xu , Fei-Yu Yang , Tian-Bing Ren , Lin Yuan , Xia Yin , Xiao-Bing Zhang . Three positive charge nonapoptotic-induced photosensitizer with excellent water solubility for tumor therapy. Chinese Chemical Letters, 2024, 35(8): 109190-. doi: 10.1016/j.cclet.2023.109190
13. [13]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
14. [14]
  Feng Wu , Xuemin Kong , Yixuan Liu , Shuli Wang , Zhong Chen , Xu Hou . Microfluidic-based isolation of circulating tumor cells with high-efficiency and high-purity. Chinese Chemical Letters, 2024, 35(8): 109754-. doi: 10.1016/j.cclet.2024.109754
15. [15]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
16. [16]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
17. [17]
  Jingqi Xin , Shupeng Han , Meichen Zheng , Chenfeng Xu , Zhongxi Huang , Bin Wang , Changmin Yu , Feifei An , Yu Ren . A nitroreductase-responsive nanoprobe with homogeneous composition and high loading for preoperative non-invasive tumor imaging and intraoperative guidance. Chinese Chemical Letters, 2024, 35(7): 109165-. doi: 10.1016/j.cclet.2023.109165
18. [18]
  Peide Zhu , Yangjia Liu , Yaoyao Tang , Siqi Zhu , Xinyang Liu , Lei Yin , Quan Liu , Zhiqiang Yu , Quan Xu , Dixian Luo , Juncheng Wang . Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chemical Letters, 2024, 35(4): 108689-. doi: 10.1016/j.cclet.2023.108689
19. [19]
  Ji Liu , Dongsheng He , Tianjiao Hao , Yumin Hu , Yan Zhao , Zhen Li , Chang Liu , Daquan Chen , Qiyue Wang , Xiaofei Xin , Yan Shen . Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters, 2024, 35(9): 109296-. doi: 10.1016/j.cclet.2023.109296
20. [20]
  Tao Wei , Jiahao Lu , Pan Zhang , Qi Zhang , Guang Yang , Ruizhi Yang , Daifen Chen , Qian Wang , Yongfu Tang . An intermittent lithium deposition model based on bimetallic MOFs derivatives for dendrite-free lithium anode with ultrahigh areal capacity. Chinese Chemical Letters, 2024, 35(8): 109122-. doi: 10.1016/j.cclet.2023.109122

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(185)
HTML views(6)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142